Document Details
Form
Filing Date
Dec 03, 2024
Document Date
Nov 21, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.